BlackRock
ZOM

BlackRock’s Zomedica Corp. ZOM Stock Holding History

BlackRock’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,821,071
Closed -$1.18M – 5594
2024
Q4 		$1.18M Hold
9,821,071
– – ﹤0.01% 4188
2024
Q3 		$1.35M Sell
9,821,071
-41,910
-0.4% -$5.88K ﹤0.01% 4108
2024
Q2 		$1.44M Hold
9,862,981
– – ﹤0.01% 4066
2024
Q1 		$1.44M Sell
9,862,981
-527,669
-5% -$73.8K ﹤0.01% 4103
2023
Q4 		$2.08M Hold
10,390,650
– – ﹤0.01% 4027
2023
Q3 		$1.74M Sell
10,390,650
-1,120,374
-10% -$218K ﹤0.01% 4051
2023
Q2 		$2.3M Buy
11,511,024
+1,264,183
+12% +$257K ﹤0.01% 3996
2023
Q1 		$2.17M Sell
10,246,841
-1,052,849
-9% -$258K ﹤0.01% 4026
2022
Q4 		$1.84M Sell
11,299,690
-21,090
-0.2% -$4.32K ﹤0.01% 4169
2022
Q3 		$2.39M Sell
11,320,780
-32,718
-0.3% -$8.66K ﹤0.01% 4097
2022
Q2 		$2.5M Sell
11,353,498
-2,064,801
-15% -$526K ﹤0.01% 4158
2022
Q1 		$4.52M Buy
13,418,299
+707,993
+6% +$232K ﹤0.01% 4024
2021
Q4 		$3.9M Sell
12,710,306
-5,403,693
-30% -$2.43M ﹤0.01% 4107
2021
Q3 		$9.48M Buy
18,113,999
+788,615
+5% +$465K ﹤0.01% 3700
2021
Q2 		$14.4M Buy
17,325,384
+154,424
+0.9% +$144K ﹤0.01% 3486
2021
Q1 		$27.1M Buy
17,170,960
+8,714,893
+103% +$14.2M ﹤0.01% 3008
2020
Q4 		$1.95M Buy
+8,456,067
New +$1.08M ﹤0.01% 4057
2020
Q3 		– Sell
-930,154
Closed -$221K – 5221
2020
Q2 		$221K Buy
+930,154
New +$177K ﹤0.01% 4357
2019
Q2 		– Sell
-1,742,080
Closed -$610K – 5128
2019
Q1 		$610K Sell
1,742,080
-25,262
-1% -$22.3K ﹤0.01% 4056
2018
Q4 		$2.17M Buy
1,767,342
+40,244
+2% +$63.8K ﹤0.01% 3636
2018
Q3 		$3.23M Buy
1,727,098
+147,828
+9% +$316K ﹤0.01% 3625
2018
Q2 		$3.55M Buy
+1,579,270
New +$3.17M ﹤0.01% 3575

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

BlackRock's ZOM Position: Q1 2025 in Review

BlackRock sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 9,821,071 shares — an estimated $1.18M sold.

BlackRock first reported a position in ZOM in Q2 2018 and held it in 22 quarters. The position peaked at $27.1M in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • BlackRock reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • BlackRock sold 9,821,071 Zomedica Corp. shares in Q1 2025, an estimated $1.18M.
  • BlackRock first reported a position in Zomedica Corp. in Q2 2018 and held it in 22 quarters.
  • BlackRock's Zomedica Corp. position peaked at $27.1M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.